Document Detail

Remote ischemic preconditioning: current knowledge, unresolved questions, and future priorities.
MedLine Citation:
PMID:  21821525     Owner:  NLM     Status:  In-Data-Review    
Remote ischemic preconditioning (RIPC) is the phenomenon whereby brief episodes of ischemia-reperfusion applied in distant tissues or organs render the myocardium resistant to a subsequent sustained episode of ischemia. Reduction of infarct size with RIPC has been documented in response to (i) brief antecedent ischemia in a remote coronary vascular bed (intra-cardiac protection); (ii) collection and transfer of coronary effluent from perconditioning "donor" hearts to naive "receptor" hearts (inter-cardiac protection); (iii) brief ischemia applied in skeletal muscle, mesentery, and other organs (interorgan protection); and (iv) remote nociception ("remote PC of trauma"). Moreover, the paradigm has expanded to encompass temporal modifications in the application of the remote stimulus (remote perconditioning and remote postconditioning). Progress has also been made in translating the concept of RIPC to patients undergoing planned ischemic events: evidence for attenuation of cardiac enzyme release with RIPC has been reported after elective abdominal aortic aneurysm repair, angioplasty, and coronary artery bypass graft surgery. However, despite these advances in characterization and clinical application, the mechanisms of RIPC-most notably, the means by which the protective stimulus is communicated to the heart-remain poorly defined and, in all likelihood, are model dependent.
Karin Przyklenk; Peter Whittaker
Related Documents :
19129135 - No energetic cost of anthropogenic disturbance in a songbird.
25239435 - Non-compaction cardiomyopathy: prevalence, prognosis, pathoetiology, genetics, and risk...
21808645 - Assessing the left ventricular systolic function at the bedside: the role of transpulmo...
25449895 - Remote ischemic conditioning: from experimental observation to clinical application: re...
12730055 - Novel 3d culture system for study of cardiac myocyte development.
4031725 - Effects of tachycardia with normal and ectopic ventricular activation on s-t segment po...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cardiovascular pharmacology and therapeutics     Volume:  16     ISSN:  1940-4034     ISO Abbreviation:  J. Cardiovasc. Pharmacol. Ther.     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-08-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602617     Medline TA:  J Cardiovasc Pharmacol Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  255-9     Citation Subset:  IM    
1Cardiovascular Research Institute, Wayne State University School of Medicine, Detroit, MI, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Clinically useful cardioprotection: ischemic preconditioning then and now.
Next Document:  Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and f...